Johnson & Johnson annual debt-to-assets ratio
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Johnson & Johnson Debt-to-Assets Ratio Growth & History (JNJ)
Johnson & Johnson's debt-to-assets ratio was 0.25 for fiscal 2025.
View full Johnson & Johnson company overviewJohnson & Johnson annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-28 | 0.25 | 0.04 | +17.85% |
| 2024 | 2024-12-29 | 0.21 | 0.03 | +15.53% |
| 2023 | 2023-12-31 | 0.18 | −0.04 | −16.83% |
| 2022 | 2023-01-01 | 0.22 | 0.03 | +14.46% |
| 2021 | 2022-01-02 | 0.19 | −0.02 | −8.01% |
| 2020 | 2021-01-04 | 0.21 | 0.03 | +14.20% |
| 2019 | 2019-12-29 | 0.18 | −0.02 | −8.72% |
| 2018 | 2018-12-30 | 0.20 | −0.02 | −9.33% |
| 2017 | 2017-12-31 | 0.22 | 0.03 | +14.35% |
| 2016 | 2017-01-01 | 0.19 | 0.04 | +29.14% |
| 2015 | 2016-01-03 | 0.15 | 0.01 | +3.64% |
| 2014 | 2014-12-28 | 0.14 | 0.01 | +4.54% |
| 2013 | 2013-12-29 | 0.14 | 0.00 | +2.98% |
| 2012 | 2012-12-30 | 0.13 | −0.04 | −22.92% |
| 2011 | 2012-01-01 | 0.17 | 0.01 | +6.30% |
| 2010 | 2011-01-02 | 0.16 | 0.01 | +5.77% |
| 2009 | 2010-01-03 | 0.15 | 0.01 | +10.29% |
| 2008 | 2008-12-28 | 0.14 | — | — |
Johnson & Johnson quarterly debt-to-assets ratio
Q4.08
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
As of Jan 3, 2021
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-28 | 0.24 | −0.02 | −7.08% |
| Q1 2026 | 2026-03-29 | 0.27 | 0.00 | +1.45% |
| Q4 2025 | 2025-12-28 | 0.25 | 0.04 | +17.85% |
| Q3 2025 | 2025-09-28 | 0.24 | 0.04 | +18.44% |
| Q2 2025 | 2025-06-29 | 0.26 | 0.03 | +14.56% |
| Q1 2025 | 2025-03-30 | 0.27 | 0.07 | +37.95% |
| Q4 2024 | 2024-12-29 | 0.21 | 0.03 | +15.53% |
| Q3 2024 | 2024-09-29 | 0.20 | 0.02 | +11.29% |
| Q2 2024 | 2024-06-30 | 0.23 | −0.01 | −3.69% |
| Q1 2024 | 2024-03-31 | 0.20 | −0.07 | −27.56% |
| Q4 2023 | 2023-12-31 | 0.18 | −0.04 | −16.83% |
| Q3 2023 | 2023-10-01 | 0.18 | −0.00 | −1.48% |
| Q2 2023 | 2023-07-02 | 0.24 | 0.05 | +29.71% |
| Q1 2023 | 2023-04-02 | 0.27 | 0.08 | +45.26% |
| Q4 2022 | 2023-01-01 | 0.22 | 0.03 | +14.46% |
| Q3 2022 | 2022-10-02 | 0.18 | −0.01 | −3.39% |
| Q2 2022 | 2022-07-03 | 0.18 | −0.01 | −3.35% |
| Q1 2022 | 2022-04-03 | 0.19 | −0.01 | −4.59% |
| Q4 2021 | 2022-01-02 | 0.19 | — | — |
| Q3 2021 | 2021-10-03 | 0.19 | −0.03 | −14.42% |
| Q2 2021 | 2021-07-04 | 0.19 | −0.00 | −1.11% |
| Q1 2021 | 2021-04-04 | 0.19 | 0.02 | +9.47% |
| Q4 2020 | 2021-01-04 | 0.21 | 0.03 | +14.20% |
| As of Jan 3, 2021 | 2021-01-03 | 0.21 | 0.03 | +14.20% |
| Q3 2020 | 2020-09-27 | 0.22 | 0.03 | +13.88% |
| Q2 2020 | 2020-06-28 | 0.19 | −0.00 | −2.17% |
| Q1 2020 | 2020-03-29 | 0.18 | −0.02 | −11.82% |
| Q4 2019 | 2019-12-29 | 0.18 | −0.02 | −8.72% |
| Q3 2019 | 2019-09-29 | 0.19 | −0.01 | −3.22% |
| Q2 2019 | 2019-06-30 | 0.20 | −0.01 | −5.00% |
| Q1 2019 | 2019-03-31 | 0.20 | −0.01 | −2.85% |
| Q4 2018 | 2018-12-30 | 0.20 | −0.02 | −9.33% |
| Q3 2018 | 2018-09-30 | 0.20 | −0.03 | −11.15% |
| Q2 2018 | 2018-07-01 | 0.21 | −0.02 | −8.73% |
| Q1 2018 | 2018-04-01 | 0.21 | −0.02 | −7.01% |
| Q4 2017 | 2017-12-31 | 0.22 | 0.03 | +14.35% |
| Q3 2017 | 2017-10-01 | 0.23 | 0.03 | +17.50% |
| Q2 2017 | 2017-07-02 | 0.23 | 0.04 | +20.54% |
| Q1 2017 | 2017-04-02 | 0.22 | 0.05 | +30.33% |
| Q4 2016 | 2017-01-01 | 0.19 | 0.04 | +29.14% |
| Q3 2016 | 2016-10-02 | 0.19 | 0.04 | +29.74% |
| Q2 2016 | 2016-07-03 | 0.19 | 0.04 | +28.36% |
| Q1 2016 | 2016-04-03 | 0.17 | 0.02 | +16.10% |
| Q4 2015 | 2016-01-03 | 0.15 | 0.01 | +3.64% |
| Q3 2015 | 2015-09-27 | 0.15 | 0.03 | +28.23% |
| Q2 2015 | 2015-06-28 | 0.15 | 0.02 | +15.46% |
| Q1 2015 | 2015-03-29 | 0.15 | 0.02 | +13.83% |
| Q4 2014 | 2014-12-28 | 0.14 | 0.01 | +4.54% |
| Q3 2014 | 2014-09-28 | 0.12 | −0.00 | −2.89% |
| Q2 2014 | 2014-06-29 | 0.13 | 0.01 | +5.09% |
| Q1 2014 | 2014-03-30 | 0.13 | −0.00 | −0.82% |
| Q4 2013 | 2013-12-29 | 0.14 | 0.00 | +2.98% |
| Q3 2013 | 2013-09-29 | 0.12 | −0.02 | −15.99% |
| Q2 2013 | 2013-06-30 | 0.12 | −0.03 | −20.59% |
| Q1 2013 | 2013-03-31 | 0.13 | −0.04 | −21.88% |
| Q4 2012 | 2012-12-30 | 0.13 | −0.04 | −22.92% |
| Q3 2012 | 2012-09-30 | 0.14 | −0.02 | −13.71% |
| Q2 2012 | 2012-07-01 | 0.15 | −0.02 | −9.15% |
| Q1 2012 | 2012-04-01 | 0.17 | 0.00 | +1.53% |
| Q4 2011 | 2012-01-01 | 0.17 | 0.01 | +6.30% |
| Q3 2011 | 2011-10-02 | 0.16 | 0.04 | +34.13% |
| Q2 2011 | 2011-07-03 | 0.17 | 0.04 | +32.31% |
| Q1 2011 | 2011-04-03 | 0.16 | 0.04 | +27.28% |
| Q4 2010 | 2011-01-02 | 0.16 | 0.01 | +5.77% |
| Q3 2010 | 2010-10-03 | 0.12 | −0.00 | −3.39% |
| Q2 2010 | 2010-07-04 | 0.13 | −0.03 | −18.92% |
| Q1 2010 | 2010-04-04 | 0.13 | — | — |
| Q4 2009 | 2010-01-03 | 0.15 | 0.01 | +10.29% |
| Q3 2009 | 2009-09-27 | 0.13 | — | — |
| Q2 2009 | 2009-06-28 | 0.16 | — | — |
| Q4 2008 | 2008-12-28 | 0.14 | — | — |
Johnson & Johnson debt-to-assets ratio trends
Over the last five fiscal years, Johnson & Johnson's debt-to-assets ratio increased from 0.21 to 0.25, a change of 0.04. The latest reported quarter, Q2 2026, shows 0.24.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Johnson & Johnson source filings ↗Community posts
Apollo reportedly nears $20 billion talks for J&J orthopedics business
Apollo ($APO) is in talks to acquire Johnson & Johnson’s ($JNJ) DePuy Synthes orthopedics business in a transaction that could be worth around $20 billion, Reuters reported, citing Bloomberg. The unit generated approximately $9.3 billion in ...